Share this article
LAS VEGAS, April 13, 2021 /PRNewswire/ DelveInsight s
Ascites Market report provides a thorough comprehension of the Ascites, historical and forecasted epidemiology, and the Ascites market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Ascites market report also proffers an analysis of the current Ascites treatment algorithm/practice, market drivers, market barriers, and unmet medical needs.
Some of the key takeaways of the
Tolvaptan, a novel aquaporin modulator, was made available in Japan in 2013 to treat patients with refractory Ascites due to cirrhosis. However, it is not approved in Japan for the Ascites treatment.
For 11 Years in a Row, Randstad Sourceright Named a Leader in Everest Group s Recruitment Process Outsourcing (RPO) PEAK Matrix® Assessment 2021
News provided by
Share this article
ATLANTA, April 13, 2021 /PRNewswire/ Global talent solutions provider
Randstad Sourceright today announced that it has been recognized as a Leader in Everest Group s Recruitment Process Outsourcing (RPO)
Randstad Sourceright was also evaluated high on the Vision & Capability scale, which measures a provider s ability to deliver services successfully among market share Leaders and was evaluated high on the Market Impact scale. It is an honor to once again be named an RPO Leader by Everest Group, said Michael Smith, Global CEO of Randstad Sourceright. This recognition is a testament to our team s commitment to delivering strategic RPO solutions that help employers remain agile while building sustainable talent pipelines, which has been and will continue to be especially important in our cur
Share this article
LAS VEGAS, April 8, 2021 /PRNewswire/ DelveInsight s
Epidermal Growth Factor Receptor (EGFR) Inhibitors-Induced Skin Disorders Market report provides a thorough comprehension of the EGFR Inhibitors-Induced Skin Disorders, historical and forecasted epidemiology, and the Epidermal Growth Factor Receptor Inhibitors-Induced Skin Disorders market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The EGFR Inhibitors-Induced Skin Disorders market report also proffers an analysis of the current EGFR Inhibitors-Induced Skin Disorders treatment algorithm/practice, market drivers, market barriers, and unmet medical needs.
Some of the key takeaways of the
There is no approved therapy specific for anti-EGFR induced skin diseases in the US, EU, and Japan.
4 Best Reasons For Rosé Right Now forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.
Share this article
LAS VEGAS, April 7, 2021 /PRNewswire/ DelveInsight s
Cluster Headache Market report provides a thorough comprehension of the Cluster Headache, historical and forecasted epidemiology, and the Cluster Headache market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Cluster Headache market report also proffers an analysis of the current Cluster Headache treatment algorithm/practice, market drivers, market barriers, and unmet medical needs.
Some of the key takea
ways of the
Many patients are undertreated, and in some cases, not treated. Cluster Headache patients are more likely to use prescription and nonprescription pain medications, including opiates.